Frictional purpuric eruption associated with angiotensin II receptor blockers.
Angiotensin II receptor blockers (ARBs) are drugs generally well tolerated. There are few reports about cutaneous side effects of ARBs. The present authors describe herein four cases of purpuric eruption mainly involving sites of friction in patients taking ARBs. These eruptions completely cleared after stopping the drug and implementing preservative measures to reduce friction.
Department of Biomedical Sciences and Human Oncology, Section of Dermatology, University of Bari Medical School, Bari, Italy.
Caterina
C
Foti
Anna Maria
AM
Carbonara
Stefania
S
Guida
Annarita
A
Antelmi
Antonio
A
Mazzocca
Paolo
P
Romita
Domenico
D
Bonamonte
Giovanni
G
Angelini
D000369:Aged, 80 and over; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D057915:Drug Substitution; D005076:Exanthema / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D005260:Female; D017276:Friction; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents
angiotensin II receptor blockers; cutaneous side effects; purpuric dermatitis